CARRIE DYLLA: Open Payments
NPI 1245274240 · WATERTOWN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 109 payments from 19 companies in 2025. Trend: 2023 $699 · 2024 $1,008 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $289 |
| Neurocrine BioSciences, Inc. | 16 | $192 |
| Teva Pharmaceuticals USA, Inc. | 11 | $136 |
| Alkermes, Inc. | 6 | $122 |
| Janssen Pharmaceuticals, Inc | 6 | $100 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, Auvelity, COBENFY, FANAPT, ARISTADA, CAPLYTA.
Industry payments across SD — which companies pay providers there.
